Technology & Innovation

Automated Insulin Delivery (AID) Algorithms

Automated Insulin Delivery (AID) algorithms serve as the control logic for Artificial Pancreas systems, primarily utilizing Model Predictive Control (MPC) to forecast glucose trends and adjust insulin delivery proactively. While PID controllers were used historically, the industry has shifted toward MPC (Tandem, Insulet) and Adaptive Learning (Beta Bionics) to manage the physiological lag of subcutaneous insulin.

Key Innovations:

  • Tandem Control-IQ: Integrates TypeZero's MPC for distinct sleep/activity profiles.
  • Medtronic 780G: Focuses on aggressive auto-correction boluses.
  • Beta Bionics: Eliminates carb counting via weight-based adaptive initialization.

Critical Risks:

  • Pharmacokinetic Lag: Insulin absorbs slower than food digests, limiting the algorithm's ability to flatten meal spikes without causing subsequent hypoglycemia.
  • Data Dependency: Sensor compression lows or Bluetooth disconnects force systems into "Open Loop" safety modes, disrupting automated therapy.
2 min read
Advanced
2 glossary terms

Introduction to Automated Insulin Delivery (AID) Algorithms

Automated Insulin Delivery (AID) algorithms are the core components of Artificial Pancreas systems, primarily utilizing Model Predictive Control (MPC) to forecast glucose trends and adjust insulin delivery proactively [1]. Historically, PID controllers were used, but the industry has shifted toward MPC (Tandem, Insulet) and Adaptive Learning (Beta Bionics) to manage the physiological lag of subcutaneous insulin [2].

Key Components of AID Algorithms

AID algorithms rely on several key components, including:

  • Glucose Sensors: Continuous glucose monitoring systems that provide real-time glucose data [6].
  • Insulin Pumps: Devices that deliver insulin based on the algorithm's calculations.
  • Control Algorithms: The software that analyzes glucose data and adjusts insulin delivery.

Innovations in AID Algorithms

Recent innovations in AID algorithms include:

  • Tandem Control-IQ: Integrates TypeZero's MPC for distinct sleep/activity profiles, allowing for more personalized insulin delivery [3].
  • Medtronic 780G: Focuses on aggressive auto-correction boluses to improve glucose control [4].
  • Beta Bionics: Eliminates carb counting via weight-based adaptive initialization, simplifying the insulin dosing process [5].

Challenges and Limitations

Despite the advancements in AID algorithms, there are still challenges and limitations to be addressed:

  • Pharmacokinetic Lag: Insulin absorbs slower than food digests, limiting the algorithm's ability to flatten meal spikes without causing subsequent hypoglycemia [6].
  • Data Dependency: Sensor compression lows or Bluetooth disconnects force systems into \

Was this article helpful?

Explore More Topics

Continue your CGM research with related categories